Federico Carrabetta

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Patients With Inflammatory Bowel Disease

Mesenchymal Stem Cells

Ulcerative Colitis

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Carmen De Caro, Rocco Spagnuolo, Angela Quirino, Elisa Mazza, Federico Carrabetta, Samantha Maurotti, Cristina Cosco, Francesco Bennardo, Roberta Roberti, Emilio Russo, Amerigo Giudice, Arturo Pujia, Patrizia Doldo, Giovanni Matera, Nadia Marascio
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study. International journal of molecular sciences 25 (10) (2024)
Carmen De Caro, Rocco Spagnuolo, Angela Quirino, Elisa Mazza, Federico Carrabetta, Samantha Maurotti, Cristina Cosco, Francesco Bennardo, Roberta Roberti, Emilio Russo, Amerigo Giudice, Arturo Pujia, Patrizia Doldo, Giovanni Matera, Nadia Marascio
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study. International journal of molecular sciences 25 (10) (2024)
Grazia Pavia, Rocco Spagnuolo, Angela Quirino, Nadia Marascio, Aida Giancotti, Silvio Simeone, Cristina Cosco, Elena Tino, Federico Carrabetta, Gianfranco Di Gennaro, Carmelo Nobile, Aida Bianco, Giovanni Matera, Patrizia Doldo
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment. Vaccines 11 (3) (2023)
Grazia Pavia, Rocco Spagnuolo, Angela Quirino, Nadia Marascio, Aida Giancotti, Silvio Simeone, Cristina Cosco, Elena Tino, Federico Carrabetta, Gianfranco Di Gennaro, Carmelo Nobile, Aida Bianco, Giovanni Matera, Patrizia Doldo
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment. Vaccines 11 (3) (2023)